SCHEMBL25610962

SCHEMBL25610962

CCCC(C)c1cc(C)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21091000 0.84 UHRF1 (0.32) —
SCHEMBL23030905 0.82 — —
SCHEMBL2625482 0.74 NOS3 (0.35) —
SCHEMBL21711086 0.73 MAPT (0.33) —
SCHEMBL21711177 0.73 NOS3 (0.38) —
SCHEMBL18672385 0.72 UHRF1 (0.42) —
SCHEMBL11981613 0.71 UHRF1 (0.32) —
SCHEMBL15806351 0.71 UHRF1 (0.32) —
SCHEMBL25098459 0.71 UHRF1 (0.32) —
SCHEMBL15806350 0.71 APLNR (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102209-A1 CLAUDIN INHIBITORS AND METHODS OF USE THEREOF THE UNIVERSITY OF CHICAGO (US) 2023-06-08 — — WO disclosed
Send feedback